Please login to the form below

Not currently logged in
Email:
Password:

McCann Health expands consulting team

Two new managing directors appointed

Business consultancy McCann Health has appointed two new managing directors - Robert Paglia and Randy Goodman - to the firm as a result of expanding projects.

Prior to McCann Health, Robert Paglia has held a number of senior roles such as US head, pricing and market access for PriceSpective, founder and president of Evolution Health Initiatives and various sales and marketing positions at Johnson & Johnson, Purdue Pharma and Bristol-Myers Squibb.

In addition to Paglia, Randy Goodman joins McCann Health bringing more than 23 years of experience from both the public and private sector.

Previously serving Healthcare Management Solutions as its senior director and project leader for health economics, global reimbursement and healthcare policy, Goodman’s expertise lies in public healthcare, economics and healthcare policy.

Goodman also worked for the White House office on reform and health policy during both the Clinton and Obama administrations.

Simon Holt, president of consulting at McCann Health, said: “We’re delighted to welcome two new senior executives to the NY management team with expertise in developing new approaches to meet the needs of today’s customers, more effective market access and pricing solutions, and fresh approaches to embedding the latest marketing and business strategies into entire organisations.”

11th April 2017

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics